Among IDH-mut gliomas the presence of homozygous cyclin-dependent kinase inhibitor 2 A/B (CDKN2A/B) gene deletions of the chromosome 9p21 are associated with significantly poorer prognosis [1, 2, 19, 32, 35, 40]. The gene discussed is CDKN2A; the disease is glioma.